On July 13, 2021, the Board of Directors of Establishment Labs Holdings Inc. appointed Ms. Ann Custin and Mr. Bryan Slotkin to the Board, effective immediately. Ms. Custin and Mr. Slotkin will both serve as Class III directors, with their respective terms expiring at the annual meeting of stockholders to be held in 2024 when they are both expected to stand for election by a vote of the Company’s stockholders. In addition, the Board appointed Ms. Custin as a member of the Board’s Audit Committee and Compensation Committee and Mr. Slotkin as a member of the Audit Committee and the Nominating and Corporate Governance Committee, both effective immediately. Ms. Custin served as Chief Financial Officer and on the board of directors of Siemens Medical Solutions Inc. from February 2012 to December 2019, retiring following such tenure. The Board has nominated Ms. Custin for election as a director because of her extensive expertise in business and experience with large medical device companies. The Board has determined that Ms. Custin qualifies as an Audit Committee Financial Expert due to her prior experience, including her previous roles as Chief Financial Officer of the various enterprises referenced above. The Board has nominated Mr. Slotkin for election as a director because of his extensive expertise in business and experience advising public company boards. The Board has determined that Mr. Slotkin qualifies as an Audit Committee Financial Expert due to his prior experience as an investment banker advising companies on complex financial transactions.